Literature DB >> 10398517

Evaluation of the use of two human cell lines for okadaic acid and DTX-1 determination by cytotoxicity assays and damage characterization.

G Oteri1, A Stammati, F Zampaglioni, F Zucco.   

Abstract

Two human cell lines have been used, HEp-2 and (de)differentiated Caco-2, derived from a larynx and a colon carcinoma, respectively, with the aim of evaluating and characterizing the cytotoxicity of okadaic acid (OA) and related toxins. Effects of OA and dinophysistoxin-1 (DTX-1) on cell viability (neutral red uptake) and on cell morphology/cytoskeleton structure have been observed in both cell lines, though at different time exposures and with different concentrations. The morphological alteration was detected earlier than the viability inhibition in HEp-2 cells with both toxins and in Caco-2 cells with DTX-1. HEp-2 cells have shown to be more sensitive than the intestinal cell line and thus possibly suitable for screening of contaminated samples, while Caco-2 cells could be used for further investigating the possible mechanisms involved in diarrhoeic shellfish poisoning (DSP) toxins. Copyright 1998 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10398517     DOI: 10.1002/(sici)1522-7189(199809/10)6:5<197::aid-nt21>3.0.co;2-n

Source DB:  PubMed          Journal:  Nat Toxins        ISSN: 1056-9014


  2 in total

1.  Evaluation of cytotoxic compounds in different organs of the sea bream Sarpa salpa as related to phytoplankton consumption: an in vitro study in human liver cell lines HepG2 and WRL68.

Authors:  Khaled Bellassoued; Asma Hamza; Jos Van Pelt; Abdelfattah Elfeki
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-07-21       Impact factor: 2.416

2.  Differences in Toxic Response Induced by Three Variants of the Diarrheic Shellfish Poisoning Phycotoxins in Human Intestinal Epithelial Caco-2 Cells.

Authors:  Antoine Huguet; Olivia Drapeau; Fanny Rousselet; Hélène Quenault; Valérie Fessard
Journal:  Toxins (Basel)       Date:  2020-12-08       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.